University of Virginia, Charlottesville
Only adverse effects of spironolactone in pediatrics was alteration of potassium
Published in Food and Drug Law Weekly, June 24th, 2005
"In 2003, the Food and Drug Administration placed spironolactone on its list of drugs needing pediatric studies. To describe the use of spironolactone in a large group of children and evaluate its safety, focusing on its effects on potassium, a prospective observational study was conducted," scientists in the United States report.
M.L. Buck of the University of Virginia Health Systems explained, "Patient demographic information was collected, as well as dosing regimens, use of other medications, and potassium concentrations. Patients were grouped by diagnosis....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
More Articles from Food and Drug Law Weekly
- Abbott
U.S. FDA approval granted for once-daily Kaletra (lopinavir/ritonavir) - Able Laboratories, Inc.
Pharma firm suspends manufacturing operations, announces product recall - Alamo Pharmaceuticals
FazaClo granted monthly safety monitoring by U.S. FDA - Alcon, Inc.
U.S. FDA grants approvable letter for Retaane suspension - Arginox Pharmaceuticals
U.S. FDA grants orphan drug designation for cardiogenic shock drug - AstraZeneca
Crestor safe, effective when used according to prescribing information - More from this issue of Food and Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
